Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis

European Respiratory Journal

Volumn 34, Issue 6, 2009, Pages 1444-1451

  Izumo, T ^a   Kondo, M ^a   Nagai, A ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Bleomycin; Interferon ; Interleukin 6; Leukotriene B4; Pulmonary fibrosis; Transforming growth factor

Indexed keywords

5 [2 (2 CARBOXYETHYL) 3 [6 (4 METHOXYPHENYL) 5 HEXENYLOXY]PHENOXY]VALERIC ACID; BLEOMYCIN; GAMMA INTERFERON; HYDROXYPROLINE; ICOSANOID; INTERLEUKIN 13; INTERLEUKIN 6; LEUKOTRIENE B4; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; ANTINEOPLASTIC ANTIBIOTIC; IMMUNOSUPPRESSIVE AGENT; LEUKOTRIENE B4 RECEPTOR; ONO-LB 457; PHENYLPROPIONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; LUNG FIBROSIS; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; PROGNOSIS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; PHENYLPROPIONATES; PROGNOSIS; PULMONARY FIBROSIS; RECEPTORS, LEUKOTRIENE B4; TRANSFORMING GROWTH FACTOR BETA;

EID: 70449444879     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00143708     Document Type: Article

References (30)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
2. Murakami S, Nagaya N, Itoh T, et al. Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2006; 290: L59-L65.
3. Peters-Golden M, Henderson WR Jr. Leukotrienes. N Engl J Med 2007; 357: 1841-1854.
4. Huang SK, Peters-Golden M. Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time? Chest 2008; 133: 1442-1450.
5. Yokomizo T, Izumi T, Shimizu T. Leukotriene B4: metabolism and signal transduction. Arch Biochem Biophys 2001; 385: 231-241.
6. Brock TG, Lee YJ, Maydanski E, et al. Nuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lung. Am J Physiol Lung Cell Mol Physiol 2005; 289: L224-L232.
7. Wardlaw AJ, Hay H, Cromwell O, et al. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989; 84: 19-26.
8. Wilborn J, Bailie M, Coffey M, et al. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1996; 97: 1827-1836.
9. Yokomizo T, Kato K, Terawaki K, et al. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 2000; 192: 421-432.
10. Tager AM, Bromley SK, Medoff BD, et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 2003; 4: 982-990.
11. Medoff BD, Seung E, Wain JC, et al. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J Exp Med 2005; 202: 97-110.
12. Izumo T, Kondo M, Nagai A. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice. Life Sci 2007; 80: 1882-1886.
13. Kishikawa K, Nakao S, Matsumoto S, et al. Estimation of antagonistic activity of ONO-4057 against leukotriene B4 in humans. Adv Prostaglandin Thromboxane Leukot Res 1995; 23: 279-281.
14. Sato E, Koyama S, Masubuchi T, et al. Bleomycin stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activities. Am J Physiol 1999; 276: L941-L950.
15. Jakubzick C, Choi ES, Joshi BH, et al. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J Immunol 2003; 171: 2684-2693.
16. Furonaka M, Hattori N, Tanimoto T, et al. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther 2009; 328: 55-61.
17. Suzuki H, Aoshiba K, Yokohori N, et al. Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis. Cancer Res 2003; 63: 5054-5059.
18. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93: 440-447.
19. Peters-Golden M, Bailie M, Marshall T, et al. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 2002; 165: 229-235.
20. Failla M, Genovese T, Mazzon E, et al. Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Respir Res 2006; 7: 137.
21. Phan SH, Kunkel SL. Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production. Am J Pathol 1986; 124: 343-352.
22. Chu HW, Trudeau JB, Balzar S, et al. Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 2000; 106: 1115-1123.
23. Haribabu B, Verghese MW, Steeber DA, et al. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J Exp Med 2000; 192: 433-438.
24. Nakao A, Fujii M, Matsumura R, et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999; 104: 5-11.
25. Clark JG, Dedon TF, Wayner EA, et al. Effects of interferon-gamma on expression of cell surface receptors for collagen and deposition of newly synthesized collagen by cultured human lung fibroblasts. J Clin Invest 1989; 83: 1505-1511.
26. Varga J, Olsen A, Herhal J, et al. Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts. Eur J Clin Invest 1990; 20: 487-493.
27. Jones KP, Reynolds SP, Capper SJ, et al. Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: differences between patients with interstitial lung disease and control subjects. Clin Exp Immunol 1991; 83: 30-34.
28. Gosset P, Lassalle P, Vanhee D, et al. Production of tumor necrosis factor-a and interleukin-6 by human alveolar macrophages exposed in vitro to coal mine dust. Am J Respir Cell Mol Biol 1991; 5: 431-436.
29. Saito F, Tasaka S, Inoue K, et al. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol 2008; 38: 566-571.
30. Luppi F, Cerri S, Beghe B, et al. Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis. Respir Med 2004; 98: 1035-1044.